726 results on '"Levy, Stuart B."'
Search Results
302. Pathogenicity of conventional and debilitated Escherichia coli K12
303. Changes in Chromatin Structure Temporally Relate to Tumorigenicity and Inducibility of Friend Cell Types
304. Use of Mucoid Bacterial Mutants to Circumvent Clumping of Cells and Minicells Containing R Plasmids Derepressed for Pilus Synthesis
305. Antibiotic Resistance
306. The Spleen in Friend Leukemia. I. Prolonged Survival of Leukemic Mice After Auto-implantation of Spleen Tissue 2 3
307. Susceptible Escherichia coli Cells Can Actively Excrete Tetracyclines
308. R Factor Proteins Synthesized in Escherichia coli Minicells: Membrane-Associated R Factor Proteins
309. Recovery frequency of phages λ and M13 from human and animal faeces
310. R Factor Proteins Synthesized in Escherichia coli Minicells: Incorporation Studies with Different R Factors and Detection of Deoxyribonucleic Acid-Binding Proteins
311. Playing Antibiotic Pool: Time to Tally the Score
312. The Spleen in Friend Leukemia. II. Nonleukemic Nature of Spleen Stroma 2 3
313. Presence of EBV Antibodies in Sera from Wild Chimpanzees
314. Segregation of Transferable R Factors into Escherichia coli Minicells
315. Subcellular Localization of Salmonella enteritidis Endotoxin in Liver and Spleen of Mice and Rats
316. Release from Escherichia coli of a Galactosyltransferase Complex Active in Lipopolysaccharide Synthesis
317. Hemoglobin Differences among Kenyan Tribes
318. Surgical Treatment of Diverticular Disease of the Colon
319. Genetic Evidence that InhA of Mycobacterium smegmatisIs a Target for Triclosan
320. Triclosan: an Instructive Tale
321. Foreword.
322. Cyclic AMP Regulates Bacterial Persistence through Repression of the Oxidative Stress Response and SOS-Dependent DNA Repair in Uropathogenic Escherichia coli
323. Policy: Adaptations of avian flu virus are a cause for concern.
324. Rapid radiation in bacteria leads to a division of labour.
325. Global Antimicrobial Resistance Alerts and Implications.
326. Antimicrobial Consumer Products: Where's the Benefit? What's the Risk?
327. CORRESPONDENCE.
328. Antimicrobial resistance: bacteria on the defence.
329. Tuberculosis.
330. Antimicrobial resistance: Bacteria on the defence.
331. Triclosan targets lipid synthesis.
332. The marCGene of Escherichia coliIs Not Involved in Multiple Antibiotic Resistance
333. Evidence that Regulatory Protein MarA of Escherichia coli Represses rob by Steric Hindrance.
334. Mechanisms for Resistance in Soil.
335. Bacteremia among Kenyan Children.
336. Antibiotics.
337. The antibiotic threat.
338. Antibiotics in the Animals We Eat.
339. The Periplasmic Protein MppA Is Not Involved in Regulation of marAin Escherichia coli
340. Multidrug Resistance — A Sign of the Times.
341. Epilogue.
342. Revised Sequence of OtrB (Tet347) Tetracycline Efflux Protein from Streptomyces rimosus
343. Prudent antibiotics
344. Susceptible Escherichia coliCells Can Actively Excrete Tetracyclines
345. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli
346. Requirement of Polyphosphate by Pseudomonas fluorescens Pf0-1 for Competitive Fitness and Heat Tolerance in Laboratory Media and Sterile Soil.
347. Transketolase A, an enzyme in central metabolism, derepresses the marRAB multiple antibiotic resistance operon of Escherichia coli by interaction with MarR.
348. Consumer Antibacterial Soaps: Effective or Just Risky?
349. Antibacterial cleaning products and drug resistance.
350. The Periplasmic Protein MppA Requires an Additional Mutated Locus To Repress marA Expression in Escherichia coli.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.